REE Automotive (REE) Prices 6.38M Share Offering at $4.25/sh

REE Automotive Ltd. (Nasdaq: REE) (the “Company”), an automotive technology company and provider of full by-wire electric trucks and platforms, today announced that it has entered into securities purchase agreements with new institutional investors and certain existing strategic investors, including M&G Investments and Varana Capital, for the purchase and sale of 6,376,631 ordinary shares at a purchase price of $4.25 per share, pursuant to a registered direct offering, resulting in gross proceeds of up to approximately $27 million at closing(s) before deducting placement agent commissions and other offering expenses. The initial closing of the offering is expected to occur on or about March 19, 2025, subject to the satisfaction of customary closing conditions.

Motherson Group, an existing shareholder and one of the world’s leading automotive suppliers, has been invited to invest up to $10 million in a second closing for a fully subscribed round by no later than March 28, 2025.

The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.

This offering is being made pursuant to an effective shelf registration statement on Form F-3 (File No. 333-266902) which was declared effective by the Securities and Exchange Commission (the “SEC”) on August 25, 2022. The offering is made only by means of a prospectus which is part of the effective registration statement. A final prospectus supplement and the accompanying prospectus relating to the registered direct offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Additionally, when available, electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

You May Also Be Interested In

• enVVeno Medical (NVNO) files $100M mixed shelf
• CoStar Group acquires Zonda for $800M, adding new home data
• Kairos Pharma announces 1-for-7 reverse stock split